The killer is that talks can progress for many months only to get to a late stage when a certain part of the Big Pharma organization, perhaps commercial or legal, has an issue which results in the Big Pharma company saying no.
On October 13th a study published in Science Translational Medicine revealed that early-stage trials show a new tuberculosis vaccine may work against drug-resistant strains of that killer disease.
So after our set, still drenched in sweat, I stepped across the back of the stage, camera in hand, for what I hoped would be an impromptu photo session with The Killer.